tiprankstipranks
CV Sciences Inc (CVSI)
OTHER OTC:CVSI
Holding CVSI?
Track your performance easily

CV Sciences (CVSI) Earnings Date & Reports

473 Followers

Earnings Data

Report Date
Mar 27, 2025
TBA Not Confirmed
Period Ending
2024 (Q4)
Consensus EPS Forecast
Last Year’s EPS
Same Quarter Last Year
Based on 0 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Nov 14, 2024
|
% Change Since: -28.89%
|
Next Earnings Date:Mar 27, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mix of steady performance in revenue and gross margins, successful product launches, and strategic acquisitions. However, the company faces challenges such as a decline in unit sales, revenue impact from regulatory changes in California, and a slight decrease in cash reserves. The sentiment remains cautiously optimistic due to the company's market leadership and strategic initiatives.
Company Guidance
During the CV Sciences Q3 2024 earnings call, the company provided guidance emphasizing their strategic focus on profitability and free cash flow. They reported a consistent revenue of $3.9 million with a healthy gross margin of 46%, showing improvement from Q3 2023's 45.1%. The company maintained its #1 position in the natural product retail channel and outlined its M&A strategy, highlighted by recent acquisitions such as Elevated Softgels and Cultured Foods, expected to contribute to revenue and operational efficiency. CV Sciences launched +PlusHLTH, a line of cannabinoid-free supplements, and reported that new products accounted for nearly 53% of Q3 2024 revenue. The company's B2C segment represented 42.8% of total revenue, improving from 40.9% a year ago. The adjusted EBITDA loss was narrowed to $75,000, close to breakeven, compared to a $0.4 million loss in Q3 2023. The company also discussed its regulatory efforts and plans to mitigate legislative challenges, highlighting their continuous push for a sensible regulatory framework at the state and federal levels.
Consistent Revenue and Healthy Gross Margin
CV Sciences achieved a revenue of $3.9 million with a gross margin of 46%, consistent with previous quarters, maintaining their position in a competitive market.
Market Leadership and New Product Launch
The company maintained its #1 position in the natural product retail channel and launched +PlusHLTH, a new line of cannabinoid-free supplements with positive initial reception.
Successful M&A Strategy
CV Sciences completed acquisitions of Elevated Softgels and Cultured Foods, contributing to increased capability, scale, and anticipated cost efficiencies.
Strong B2C Performance
Direct-to-consumer business represented 42.8% of total revenue in Q3 2024, showing an increase from 40.9% a year earlier, despite a competitive market and reduced marketing spend.
---

CV Sciences (CVSI) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CVSI Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 27, 20252024 (Q4)
- / -
Nov 14, 20242024 (Q3)
- / >-0.01
-0.00333.33% (<+0.01)
Aug 13, 20242024 (Q2)
- / >-0.01
-0.0170.00% (<+0.01)
May 14, 20242024 (Q1)
- / >-0.01
0.04-110.00% (-0.04)
Mar 28, 20242023 (Q4)
- / >-0.01
-0.0150.00% (<+0.01)
Nov 14, 20232023 (Q3)
- / >-0.01
-0.0170.00% (<+0.01)
Aug 14, 20232023 (Q2)
- / -0.01
-0.0366.67% (+0.02)
May 15, 20232023 (Q1)
- / 0.04
-0.02300.00% (+0.06)
Mar 29, 20232022 (Q4)
- / -0.01
-0.0887.50% (+0.07)
Nov 14, 20222022 (Q3)
-0.02 / -0.01
0
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

CVSI Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 14, 2024$0.04$0.040.00%
Aug 13, 2024$0.06$0.05-16.67%
May 14, 2024$0.05$0.050.00%
Mar 28, 2024$0.04$0.040.00%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does CV Sciences Inc (CVSI) report earnings?
CV Sciences Inc (CVSI) is schdueled to report earning on Mar 27, 2025, TBA Not Confirmed.
    What is CV Sciences Inc (CVSI) earnings time?
    CV Sciences Inc (CVSI) earnings time is at Mar 27, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is CVSI EPS forecast?
          Currently, no data Available
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis